Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia

PHASE3TerminatedINTERVENTIONAL

Enrollment

826

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

June 30, 2009

Conditions

Hypercholesterolemia

Interventions

DRUG

AVE5530

one tablet in the evening with dinner

DRUG

Placebo

one tablet in the evening with dinner

Trial Locations (2)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, San Juan